onxeo
  • English
  • Français
>>>>
    • News
    • Agenda
    • Subscribe to news

Get to know AsiDNA

View corporate presentation

BECOME A PARTNER
BECOME A SHAREHOLDER

NEWS >

Onxeo Announces 10th Positive DSMB Recommendation to Continue Livatag® ReLive Phase III Trial in HCC

Onxeo announces allowance of U.S. patent for Livatag® in hepatocellular carcinoma

AGENDA >

2016 Full-Year Results Presentation – March 2017

March 8, 2017

Future Leaders in the Biotech Industry by Biocentury

April 7, 2017

back up ↑
  • Terms of use
  • Contact
© Copyright 2017 onxeo | The sections “The group”, “Our products”, “Partnerships”, “Investors”, “Media” are dedicated to investors. | Webdesign : Limbus Studio